Closed dportnoy closed 9 years ago
Documentation and solution updated here, based on conversations with FDA's CDER Office of Strategic Programs (OSP): http://hhs.ddod.us/wiki/Use_Case_34
Update... Checking again with originator to identify suitability of solution and next steps.
Closing, since data has been provided. Please not we're unable to get confirmation from requestor as to whether their needs were fully met.
Provide cost of drug approval process to the FDA, both historically and on an ongoing basis. This is to be used in conjunction with model identifying optimal pharmaceutical investment decisions.
See specifications, working documents, solutions for this Use Case: http://hhs.ddod.us/wiki/Use_Case_34